ICON introduced circulating tumor cell testing to North East Florida via
Veridex cell search technology in 2005. This remarkable procedure assists Oncologists in monitoring the course of metastatic breast,
colorectal, and prostatic cancer. In the summer of 2011, ICON introduced
OncImmune auto antibody testing for patients at risk of lung cancer.